Publications by authors named "Steve Pascoe"

Claim this Profile
T
The effect of exacerbation history on outcomes in the IMPACT trial.
David M G Halpin, Mark T Dransfield, MeiLan K Han, C Elaine Jones, Sally Kilbride, Steve Pascoe

Eur Respir J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised.
Steve Pascoe, Ian Pavord, David Hinds, Nicolas Locantore, Neil Barnes

Lancet Respir Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life.
Maggie Tabberer, David A Lomas, Ruby Birk, Noushin Brealey, Chang-Qing Zhu, Steve Pascoe

Adv Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.
Ian D Pavord, Sally Lettis, Nicholas Locantore, Steve Pascoe, Paul W Jones

Thorax· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis.
Paul W Jones, James F Donohue, Jerry Nedelman, Steve Pascoe, Gregory Pinault

Respir Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of formoterol in adults and children with asthma: a meta-analysis.
James Kemp, Linda Armstrong, Ying Wan, Vijay Kumar Thygarajan Alagappan, David Ohlssen, Steve Pascoe

Ann Allergy Asthma Immunol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacodynamic model of the longitudinal FEV1 response to an inhaled long-acting anti-muscarinic in COPD patients.
Kai Wu, Michael Looby, Goonaseelan Pillai, Gregory Pinault, Anton Franz Drollman, Steve Pascoe

J Pharmacokinet Pharmacodyn· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.
Hossein A Ghofrani, Nicholas W Morrell, Marius M Hoeper, Horst Olschewski, Andrew J Peacock, Steve Pascoe

Am J Respir Crit Care Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.
Salim Abdulla, Baraka Amuri, Abdunoor M Kabanywanyi, David Ubben, Christine Reynolds, Steve Pascoe

Malar J· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma.
Laurence J Brookman, Lisa J Knowles, Michaela Barbier, Brigitte Elharrar, Rainard Fuhr, Steve Pascoe

Curr Med Res Opin· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis